Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20006788HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050635HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050286HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20018566HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20050919HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20034063HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS20045082HPVENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44009720HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44033961HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TVIS44049462HTLV-1ENSG00000172572.7protein_codingPDE3ANoNo5139Q14432
TCGA Plot Options
Drug Information
GenePDE3A
DrugBank IDDB00261
Drug NameAnagrelide
Target IDBE0000436
UniProt IDQ14432
Regulation Typeinhibitor
PubMed IDs2846839; 31598394
CitationsVenuti MC, Stephenson RA, Alvarez R, Bruno JJ, Strosberg AM: Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline. J Med Chem. 1988 Nov;31(11):2136-45.@@An R, Liu J, He J, Wang F, Zhang Q, Yu Q: PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth. Am J Cancer Res. 2019 Sep 1;9(9):1905-1921. eCollection 2019.
GroupsApproved
Direct ClassificationQuinazolines
SMILESClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
Pathways
PharmGKBPA164742986
ChEMBLCHEMBL760